Validation measurements of the new generation of VOGAS exhaled breath analyzer are taking place at the Institute of Clinical and Preventive Medicine, University of Latvia

This special exhaled breath analyser have a combine electronic nose concepts utilizing gold nanoparticles and metal oxide sensors with orthogonal mid-infrared spectroscopic techniques for obtaining multi-dimensional analytical data sets. 

The healthy individuals are invited to participate in validation study. All of participants donate breath sample in all five hybrid VOGAS prototypes.  

The VOGAS project aim is a developing a non-invasive gastric cancer screening tool by detecting characteristic panels of volatile organic compounds (VOCs). 

The first clinical trials of the VOGAS project were started in November 2019 at the University of Latvia in cooperation with the Riga East Clinical University Hospital and the Digestive Diseases Center “GASTRO”. 

After validation study, the clinical studies will be conducted in parallel in European (Latvia, Ukraine) and Latin American (Colombia, Brazil, Chile) countries. Patients with gastric cancer and individuals with and without precancerous lesions will be enrolled. 

* Project has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No 824986